Abstract
The use of homology models in docking-based drug discovery is already established, and provides an effective and computationally affordable alternative whenever experimental structures are not available. Recent methodological studies have confirmed and benchmarked the feasibility of using structural models in docking. However, more accurate methods are expected to be developed in the near future, especially for the model refinement stage. In this review, the latest developments in homology modeling in the context of structure-based virtual screening are presented, together with the recent success stories of homology modeling in actual docking-based drug discovery endeavours.
Keywords: Homology modeling, ligand docking, high-throughput docking, structure-based virtual screening, protein flexibility, ligand-steered homology modeling, drug discovery, benchmarked the feasibility of using structural models in docking, model refinement stage, virtual screening, endeavours
Current Topics in Medicinal Chemistry
Title: Homology Models in Docking and High-Throughput Docking
Volume: 11 Issue: 12
Author(s): Claudio N. Cavasotto
Affiliation:
Keywords: Homology modeling, ligand docking, high-throughput docking, structure-based virtual screening, protein flexibility, ligand-steered homology modeling, drug discovery, benchmarked the feasibility of using structural models in docking, model refinement stage, virtual screening, endeavours
Abstract: The use of homology models in docking-based drug discovery is already established, and provides an effective and computationally affordable alternative whenever experimental structures are not available. Recent methodological studies have confirmed and benchmarked the feasibility of using structural models in docking. However, more accurate methods are expected to be developed in the near future, especially for the model refinement stage. In this review, the latest developments in homology modeling in the context of structure-based virtual screening are presented, together with the recent success stories of homology modeling in actual docking-based drug discovery endeavours.
Export Options
About this article
Cite this article as:
N. Cavasotto Claudio, Homology Models in Docking and High-Throughput Docking, Current Topics in Medicinal Chemistry 2011; 11 (12) . https://dx.doi.org/10.2174/156802611795860951
DOI https://dx.doi.org/10.2174/156802611795860951 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Drugs Targeting the c-Ring of the F<sub>1</sub>F<sub>O</sub>-ATP Synthase
Mini-Reviews in Medicinal Chemistry Reaction of Some Substituted 3-Aryl-4-formylsydnones with Tetra-Oacetyl- β-D-galactopyranosyl)thiosemicarbazide
Letters in Organic Chemistry Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
Current Neuropharmacology Advances of Inorganic Materials in the Detection and Therapeutic Uses against Coronaviruses
Current Medicinal Chemistry T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions
Endocrine, Metabolic & Immune Disorders - Drug Targets Vitamin D Intervention Trials in Critical Illness
Inflammation & Allergy - Drug Targets (Discontinued) Exploring Interaction of TNF and Orthopoxviral CrmB Protein by Surface Plasmon Resonance and Free Energy Calculation
Protein & Peptide Letters Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Current Medicinal Chemistry Benzothiazole-based Compounds in Antibacterial Drug Discovery
Current Medicinal Chemistry Inhibitors of Selected Bacterial Metalloenzymes
Current Medicinal Chemistry Tuberculosis: An Inorganic Medicinal Chemistry Perspective
Current Medicinal Chemistry Type 2 Diabetes and its Impact on the Immune System
Current Diabetes Reviews Oxidative Stress in HIV Patients Receiving Antiretroviral Therapy
Current HIV Research Non-Clinical Investigation of Tuberculosis Drugs: Conjugated Norbornene- Based Nanocarriers Toxic Impacts on Zebrafish
Current Nanomedicine Targeting the Formation of the Cell Wall Core of M. tuberculosis
Infectious Disorders - Drug Targets Structure and Regulation of the Drug-Metabolizing Enzymes Arylamine N-acetyltransferases
Current Medicinal Chemistry Synthesis, <i>In silico</i> and <i>In vitro</i> Analysis of Hydrazones as Potential Antituberculosis Agents
Current Computer-Aided Drug Design Multi-Drug Resistant Pulmonary Tuberculosis
Current Respiratory Medicine Reviews A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity
Anti-Cancer Agents in Medicinal Chemistry The Professional Phagocyte Dictyostelium discoideum as a Model Host for Bacterial Pathogens
Current Drug Targets